Eywa Pharma Inc. is recalling 5,451 bottles of Levetiracetam (brand name Keppra), a medication used to treat seizures. This recall was initiated after a 1000 mg Levetiracetam tablet was found inside a bottle labeled as containing 500 mg tablets. If a patient unknowingly takes a 1000 mg tablet instead of their prescribed 500 mg dose, they will receive double the intended medication, which could lead to adverse health effects. These prescription tablets were distributed nationwide in the United States.
Taking a higher dose of Levetiracetam than prescribed can cause significant side effects such as extreme drowsiness, agitation, aggression, or depressed consciousness. For patients managing epilepsy, incorrect dosing could potentially interfere with seizure control or lead to toxicity.
Contact healthcare provider and return to pharmacy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.